Darifenacin Hydrobromide extended Release IP 7.5
Nov 02, 2022
Derifenac 7.5
Darifenacin Hydrobromide extended Release IP 7.5 is used to treat an overactive bladder. By relaxing the muscles in the bladder, Darifenacin Hydrobromide extended Release IP 7.5 improves your ability to control your urination. Darifenacin Hydrobromide extended Release IP 7.5 helps to reduce leaking of urine, feelings of needing to urinate right away, and frequent trips to the bathroom.
For more information please contact:
Recent Post
How Metoprolol 25 mg & Amlodipine 2.5 mg Tablets Help Control Hypertension
Lactitol Monohydrate Syrup 66.67% w/v: Uses, Benefits, Dosage & Side Effects Explained
Why Doctors Recommend Nebivolol Hydrochloride and Cilnidipine Tablets for Hypertension
How Risedronate Sodium 35 mg Helps Strengthen Bones And Prevent Fractures ?
What is Paroxetine Hydrochloride PR 37.5 mg? Uses, Warnings & Precautions
How Ursodeoxycholic Acid and S-Adenosyl-L-Methionine Tablets Aid in Liver Disease Management
Citrus Bioflavonoids Vitamin C & Calcium Dobesilate Tablets: Complete Guide 2026
What Is Deferasirox 500 mg? A Complete Patient Guide.
Understanding Nilotinib Therapy: 150 mg vs 200 mg Capsule Strengths
Why Choose Vitamin C Chewable Tablets 500 mg for Daily Health?